Keywords: Cell Therapuetics, Pixuvri, Non-Hodgkin B-cell Lymphomas, NHL, European Commission

Cell Therapeutics' Pixuvri cleared in EU for NHL

Article | 14 May 2012

US biotech firm Cell Therapeutics (Nasdaq and MTA: CTIC) last week received conditional marketing authorization from the European Commission for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Cell Therapeutics

Go to company listing

Related Drugs

Pixuvri

Go to drug listing